Aquabeam, LLC
6 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
15
Ending by 2030
Jan 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 9, 2027The maintenance fee for Tissue Ablation and Cautery with Optical Energy Carried in Fluid Stream (US 10,342,615) comes due Jan 9, 2027. Unpaid by Jul 9, 2027, it lapses early.
- 1 fee due Mar 19, 2027The maintenance fee for Controlled Ablation with Laser Energy (US 11,759,258) comes due Mar 19, 2027. Unpaid by Sep 20, 2027, it lapses early.
- 1 fee due Jul 12, 2027The maintenance fee for Multi Fluid Tissue Resection Methods and Devices (US 9,232,959) comes due Jul 12, 2027. Unpaid by Jan 12, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,232,960 | Minimally Invasive Devices for Multi-Fluid Tissue Ablation In force · High confidence | In force | High confidence | |
| US 9,237,902 | Multi-Fluid Tissue Ablation Methods for Treatment of an Organ In force · Medium confidence | In force | Medium confidence | |
| US 10,251,665 | Multi Fluid Tissue Resection Methods and Devices In force · High confidence | In force | High confidence | |
| US 11,350,964 | Minimally Invasive Treatment Device for Tissue Resection In force · High confidence | In force | High confidence | |
| US 12,108,964 | Minimally invasive tissue treatment device In force · From the USPTO record | In force | From the USPTO record | |
| US 12,290,277 | Tissue Resection with Pressure Sensing In force · Low confidence | In force | Low confidence | |
| US 7,882,841 | Minimally Invasive Methods and Devices for the Treatment of Prostate Diseases In force · High confidence | In force | High confidence | |
| US 11,478,269 | Minimally Invasive Methods for Multi-Fluid Tissue Ablation In force · High confidence | In force | High confidence | |
| US 11,033,330 | Tissue Ablation and Cautery with Optical Energy Carried in Fluid Stream In force · High confidence | In force | High confidence | |
| US 11,172,986 | Ablation with Energy Carried in Fluid Stream In force · High confidence | In force | High confidence |
Also on record, not counted in the 16: 6 patents in force now held by others. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending